Survival analysis in breast cancer using proteomic data from four independent datasets
Ágnes Ősz, András Lánczky, Balázs Győrffy
doi: https://doi.org/10.1101/2020.12.03.20242065
Ágnes Ősz
1Semmelweis University Department of Bioinformatics, H-1094, Budapest, Hungary
3TTK Momentum Cancer Biomarker Research Group, Institute of Enzymology, H-1117, Budapest, Hungary
András Lánczky
1Semmelweis University Department of Bioinformatics, H-1094, Budapest, Hungary
Balázs Győrffy
1Semmelweis University Department of Bioinformatics, H-1094, Budapest, Hungary
2nd, H-1094, Budapest, Hungary
3TTK Momentum Cancer Biomarker Research Group, Institute of Enzymology, H-1117, Budapest, Hungary
Posted December 04, 2020.
Survival analysis in breast cancer using proteomic data from four independent datasets
Ágnes Ősz, András Lánczky, Balázs Győrffy
medRxiv 2020.12.03.20242065; doi: https://doi.org/10.1101/2020.12.03.20242065
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (688)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1015)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)